Lytix Biopharma appoints Karsten Bruins Slot as Director Clinical Development

Lytix is hiring - looking for a CMC Manager

Our CEO, Øystein Rekdal, has been interview by Health Talk

Verrica Pharmaceuticals with positive update on how they are advancing our lead compound LTX-315 through their Phase II trial

Lytix Biopharma held a CMD November 22nd, 2022 - webcast replay is available